58 related articles for article (PubMed ID: 31870198)
1. Angioimmunoblastic T-cell lymphoma in Taiwan reveals worse progression-free survival for
Hsu YT; Wang YC; Chen RY; Hung LY; Li SS; Yen CC; Chen TY; Medeiros LJ; Chang KC
Leuk Lymphoma; 2020 May; 61(5):1108-1118. PubMed ID: 31870198
[TBL] [Abstract][Full Text] [Related]
2. Parallel evolution of two distinct lymphoid proliferations in clonal haematopoiesis.
Attygalle AD; Dobson R; Chak PK; Vroobel KM; Wren D; Mugalaasi H; Morgan Y; Kaur M; Ahmad R; Chen Z; Naresh KN; Du MQ
Histopathology; 2022 Apr; 80(5):847-858. PubMed ID: 35064935
[TBL] [Abstract][Full Text] [Related]
3. Genetic abnormalities assist in pathological diagnosis and EBV-positive cell density impact survival in Chinese angioimmunoblastic T-cell lymphoma patients.
Shi Y; Wang H; Liu Y; Long M; Ding N; Mi L; Lai Y; Zhou L; Diao X; Li X; Liu W; Zhu J
Chin J Cancer Res; 2023 Oct; 35(5):536-549. PubMed ID: 37969960
[TBL] [Abstract][Full Text] [Related]
4. Clonal germinal center B cells function as a niche for T-cell lymphoma.
Fujisawa M; Nguyen TB; Abe Y; Suehara Y; Fukumoto K; Suma S; Makishima K; Kaneko C; Nguyen YTM; Usuki K; Narita K; Matsue K; Nakamura N; Ishikawa S; Miura F; Ito T; Suzuki A; Suzuki Y; Mizuno S; Takahashi S; Chiba S; Sakata-Yanagimoto M
Blood; 2022 Nov; 140(18):1937-1950. PubMed ID: 35921527
[TBL] [Abstract][Full Text] [Related]
5. Angioimmunoblastic T-cell lymphoma and Kaposi sarcoma: A fortuitous collision?
Poullot E; Milowich D; Lemonnier F; Bisig B; Robe C; Pelletier L; Letourneau A; Dupuy A; Sako N; Ketterer N; Carde P; Dartigues P; Delfau-Larue MH; de Leval L; Gaulard P
Histopathology; 2024 Feb; 84(3):556-564. PubMed ID: 37988271
[TBL] [Abstract][Full Text] [Related]
6. [Mutation characteristics of angioimmunoblastic T-cell lymphoma: an analysis of 75 cases].
Shen X; Yi HM; Li AQ; Ouyang BS; Dong L; Wang CF
Zhonghua Bing Li Xue Za Zhi; 2024 Jan; 53(1):29-33. PubMed ID: 38178743
[No Abstract] [Full Text] [Related]
7. Early detection of T-cell lymphoma with T follicular helper phenotype by RHOA mutation analysis.
Dobson R; Du PY; Rásó-Barnett L; Yao WQ; Chen Z; Casa C; Ei-Daly H; Farkas L; Soilleux E; Wright P; Grant JW; Rodriguez-Justo M; Follows GA; Rashed H; Fabre M; Baxter EJ; Vassiliou G; Wotherspoon A; Attygalle AD; Liu H; Du MQ
Haematologica; 2022 Feb; 107(2):489-499. PubMed ID: 33567811
[TBL] [Abstract][Full Text] [Related]
8. Angioimmunoblastic T-cell lymphoma: Novel recurrent mutations and prognostic biomarkers by cell-free DNA profiling.
Zhang C; Mou B; Xu J; Wang J; Liu Q; Yang Y; Tang W; Zhong X; Xu C
Br J Haematol; 2023 Dec; 203(5):807-819. PubMed ID: 37646306
[TBL] [Abstract][Full Text] [Related]
9. Overlap at the molecular and immunohistochemical levels between angioimmunoblastic T-cell lymphoma and a subgroup of peripheral T-cell lymphomas without specific morphological features.
Manso R; González-Rincón J; Rodríguez-Justo M; Roncador G; Gómez S; Sánchez-Beato M; Piris MA; Rodríguez-Pinilla SM
Oncotarget; 2018 Mar; 9(22):16124-16133. PubMed ID: 29662631
[TBL] [Abstract][Full Text] [Related]
10. Angioimmunoblastic T-cell lymphoma involving the nasopharynx: An easily misdiagnosed disease with atypical histopathological features.
Xu T; Zhang X; Zhu J; Huang C; Zhou M; Hu L; Guo L; Lin S; Lin X; Zang S
Hum Pathol; 2024 Mar; 145():86-94. PubMed ID: 38431056
[TBL] [Abstract][Full Text] [Related]
11. Angioimmunoblastic T-cell Lymphoma Mimicking Systemic Lupus Erythematosus: A Case Report and Literature Review.
Wang Y; Pan Z
Altern Ther Health Med; 2023 Nov; 29(8):733-737. PubMed ID: 37708543
[TBL] [Abstract][Full Text] [Related]
12. Correlation of mutational landscape and survival outcome of peripheral T-cell lymphomas.
Ye Y; Ding N; Mi L; Shi Y; Liu W; Song Y; Shu S; Zhu J
Exp Hematol Oncol; 2021 Feb; 10(1):9. PubMed ID: 33546774
[TBL] [Abstract][Full Text] [Related]
13. Clinical and histological study of follicular helper T-cell lymphomas with indolent evolution.
Messéant O; Drieux F; Sako N; Fataccioli V; Camus V; Robe C; Houot R; Tas P; Llamas-Gutierrez F; Lamaison C; Abraham J; Delage-Corre M; Benguerfi S; Bossard JB; Gaulard P; Lemonnier F
Eur J Cancer; 2024 Jan; 197():113479. PubMed ID: 38128263
[TBL] [Abstract][Full Text] [Related]
14. [TFH lymphoma and associated clonal hematopoiesis].
Nann D; Fend F; Quintanilla-Martinez L
Pathologie (Heidelb); 2023 Dec; 44(Suppl 3):144-149. PubMed ID: 37870568
[TBL] [Abstract][Full Text] [Related]
15. Clinical features and prognostic outcomes of angioimmunoblastic T cell lymphoma in an Asian multicenter study.
Chang EWY; Yang VS; Ong SY; Kang HX; Lim BY; de Mel S; Ng EKY; Poon ML; Tan YH; Chiang J; Poon E; Somasundaram N; Farid M; Tang T; Tao M; Khoo LP; Cheng CL; Huang D; Ong CK; Lim ST; Chan JY
Leuk Lymphoma; 2023; 64(11):1782-1791. PubMed ID: 37477443
[TBL] [Abstract][Full Text] [Related]
16. Angioimmunoblastic T-cell lymphoma after acute myeloid leukemia: Alleged common pathogenesis. A case report and literature review.
Iturrate I; Loscertales J; Fernández-Ruiz E; Muñoz P; López C; Del Campo L; Muñoz C; Alegre A
Clin Case Rep; 2020 Dec; 8(12):3494-3497. PubMed ID: 33363958
[TBL] [Abstract][Full Text] [Related]
17. Angioimmunoblastic T-cell lymphoma-like lymphadenopathy in mice transgenic for human
Lee GJ; Jun Y; Yoo HY; Jeon YK; Lee D; Lee S; Kim J
Oncoimmunology; 2020 May; 9(1):1746553. PubMed ID: 32923110
[TBL] [Abstract][Full Text] [Related]
18. RHOA mutation in follicular T-cell lymphoma: Clinicopathological analysis of 16 cases.
Miyoshi H; Sakata-Yanagimoto M; Shimono J; Yoshida N; Hattori K; Arakawa F; Yanagida E; Takeuchi M; Yamada K; Suzuki T; Moritsubo M; Furuta T; Chiba S; Ohshima K
Pathol Int; 2020 Sep; 70(9):653-660. PubMed ID: 32648273
[TBL] [Abstract][Full Text] [Related]
19. Dasatinib Is an Effective Treatment for Angioimmunoblastic T-cell Lymphoma.
Nguyen TB; Sakata-Yanagimoto M; Fujisawa M; Nuhat ST; Miyoshi H; Nannya Y; Hashimoto K; Fukumoto K; Bernard OA; Kiyoki Y; Ishitsuka K; Momose H; Sukegawa S; Shinagawa A; Suyama T; Sato Y; Nishikii H; Obara N; Kusakabe M; Yanagimoto S; Ogawa S; Ohshima K; Chiba S
Cancer Res; 2020 May; 80(9):1875-1884. PubMed ID: 32107212
[TBL] [Abstract][Full Text] [Related]
20. Integrative analysis of a phase 2 trial combining lenalidomide with CHOP in angioimmunoblastic T-cell lymphoma.
Lemonnier F; Safar V; Beldi-Ferchiou A; Cottereau AS; Bachy E; Cartron G; Fataccioli V; Pelletier L; Robe C; Letourneau A; Missiaglia E; Fourati S; Moles-Moreau MP; Delmer A; Bouabdallah R; Voillat L; Becker S; Bossard C; Parrens M; Casasnovas O; Cacheux V; Régny C; Camus V; Delfau-Larue MH; Meignan M; de Leval L; Gaulard P; Haioun C
Blood Adv; 2021 Jan; 5(2):539-548. PubMed ID: 33496747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]